Quinten Health, Aetion partner on AI for research studies

By The Science Advisory Board staff writers

September 23, 2021 -- Artificial intelligence (AI) developer Quinten Health and Aetion, a real-world evidence technology provider, have formed a strategic partnership to offer an integrated range of products and services.

The partnership will leverage Quinten Health's analytics and AI products and Aetion's evidence platform, which analyzes real-world data to produce transparent and scientifically validated evidence on the safety, efficacy, and value of medical treatments and technologies, the companies said.

The partnership allows clinicians, biopharma, and regulatory and health technology assessment agencies to use Quinten Health's AI and machine-learning algorithms to generate a range of scientific hypotheses and then validate those hypotheses using Aetion's evidence platform.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.